Jump Financial, LLC Immutep LTD Transaction History

Jump Financial, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$2.3 - $3.61 $40,250 - $63,175	-17,500 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$3.09 - $4.81 $50,246 - $78,215	-16,261 Reduced 48.17%	17,500 $57,000
Q3 2021 Nov 12, 2021	BUY	$3.17 - $4.39 $30,625 - $42,411	9,661 Added 40.09%	33,761 $131,000
Q2 2021 Aug 13, 2021	BUY	$3.02 - $5.21 $72,782 - $125,561	24,100 New	24,100 $93,000

2.41M

526K

222K

Ticker IMMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,000
Market Cap $172M
Description
Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.